CN105343970B - A kind of medication follow-up mechanism and its method for tracing - Google Patents

Abstract

The invention discloses a medication tracking device and a tracking method thereof, which include a casing assembly, a detection probe and a controller assembly; the casing assembly is sleeved on an inhaler, and the casing assembly includes an upper casing and a lower casing , a plurality of connecting columns and a plurality of insertion slots; the controller assembly includes a main control wireless device, a position detection device, a wireless communication device, an audible and visual reminder device and a power supply; the detection probe and the controller assembly are respectively arranged in In the shell assembly, the inhaler is provided with a plurality of detection grooves, and the detection probe is slidably connected with the detection grooves. The invention can automatically record the patient's medication information, including the time, dose, location, etc. of the medication. The information can be exchanged with the smart device through wireless data, and the medication can be reminded by sound and light.

Description

Medication tracking device and tracking method thereof

technical field

The invention relates to a third-party accessory of a drug inhalation device, in particular to a drug tracking device and a tracking method thereof.

Background technique

There are currently about 30 million asthmatics in China, and more than 95% of them have not been able to effectively control their asthma. Asthma patients require long-term inhaled controller medications to control the development of inflammation.

Seretide (scientific name salmeterol-ticasone powder inhalation) is a compound drug widely used in the regular treatment of reversible obstructive airway diseases, including asthma in adults and children.

By analyzing the patient's medication information, including medication dosage, medication time, medication location, etc., it is possible to understand the patient's medication compliance, effect after medication, and changes in the condition. On the other hand, these information can provide the basis for the doctor's diagnosis and treatment.

Seretide is a dry powder inhaler that needs to be administered with a disc inhaler "acceptor". The use of the "acceptor" includes a series of actions such as opening the suction port, administering the drug, and closing the suction port.

Contents of the invention

The purpose of the present invention is to provide a medication tracking device and a tracking method thereof, which can track and record information related to patients' medication.

In order to achieve the above object, technical scheme of the present invention is:

A medication tracking device, comprising a shell assembly, a detection probe and a controller assembly; the shell assembly is sleeved on the inhaler, and the shell assembly includes an upper shell, a lower shell, a plurality of connecting posts and a plurality of The insertion slot; the upper casing is fitted with a cover on the upper surface of the inhaler, and one end of the upper casing is open and forms an arc-shaped groove, so that the opening of the inhaler is exposed on the upper casing The outside of the arc-shaped groove; the lower casing fits the cover on the lower end surface of the inhaler, and one end of the lower casing is open and forms an arc-shaped groove, so that the opening of the inhaler is exposed on the outside the arc-shaped groove of the lower casing; the plurality of connecting columns are respectively arranged at intervals on the inner walls of the upper casing and the lower casing, and are located at the edges of the upper casing and the lower casing , the plurality of insertion slots are arranged at intervals on the inner walls of the upper case and the lower case, and are located at the edges of the upper case and the lower case, and the plurality of connecting columns and the plurality of The insertion slots are adapted so that the upper casing and the lower casing are plugged and fixed; the detection probe and the controller assembly are respectively arranged in the casing assembly, and the inhaler is provided with multiple a detection groove, and the detection probe is slidably connected with the detection groove.

The above medication tracking device, wherein the controller component includes a main control wireless device, a position detection device, a wireless communication device, an audible and visual reminder device, and a power supply; the output terminals of the position detection device and the power supply are connected to the The input end of the main control wireless device is connected, the wireless communication device is bidirectionally connected with the main control wireless device, the wireless communication device is connected to an external smart device, the output end of the main control wireless device is connected to the The input end of the sound and light reminder device is connected; the detection probe is connected with the main control wireless device.

In the above medication tracking device, wherein the position detecting device is a GPS chip or a GPRS chip of model ATK-SIM900, and the position synchronization is realized by base station LBS technology.

In the above medication tracking device, wherein the wireless communication device is a separate communication device whose model is mcu+ble/gprs/gps.

In the above medication tracking device, the wireless communication device is an integrated communication device modeled as NRF51822/CC2541+gprs/gps.

The above medication tracking device, wherein, the power supply is a button battery or a lithium battery.

A tracking method for a medication tracking device, wherein the method at least includes the following steps:

Step 1: System initialization.

Step 2: The detection probe determines whether to perform drug detection, if yes, execute step 3, if not, execute step 4.

Step 3: The main control wireless device records the medication information.

Step 4: The main control wireless device judges whether to carry out medication reminder, if yes, execute step 5, if not, execute step 6.

Step 5: Carrying out sound and light reminder for medication through the sound and light reminder device.

Step 6: The main control wireless device judges whether to perform data communication, if yes, execute step 7, if not, execute step 8.

Step 7: wirelessly connect the smart device through the wireless communication device, and perform data interaction.

Step 8: The controller component enters a low power consumption state, and returns to step 2.

The tracking method of the above-mentioned medication tracking device, wherein, in the step 3, the information of the medication includes the time, dose and location of the medication.

The invention can automatically record the patient's medication information, including the time, dosage, location, etc. of the medication, and the information can be wirelessly and intelligently exchanged for data, and can also remind the medication through sound and light.

Description of drawings

Fig. 1 is a bottom view of an upper casing of a medication tracking device of the present invention.

Fig. 2 is a top view of the lower casing of a medication tracking device of the present invention.

Fig. 3 is a detection state diagram of a detection probe of a medication tracking device of the present invention.

Fig. 4 is a connection block diagram of a controller component of a medication tracking device of the present invention.

Fig. 5 is a flowchart of a tracking method of a medication tracking device of the present invention.

Detailed ways

Embodiments of the present invention will be further described below in conjunction with the accompanying drawings.

Please refer to accompanying drawings 1 to 3, a drug tracking device includes a housing assembly, a detection probe 1 and a controller assembly; the housing assembly is sleeved on the inhaler, and the housing assembly includes an upper shell Body 21, lower casing 22, multiple connecting posts 23 and multiple insertion grooves 24; the upper casing 21 is fitted with a cover on the upper end surface of the inhaler, one end of the upper casing 21 is open and An arc-shaped groove body 25 is formed, so that the opening of the inhaler is exposed outside the arc-shaped groove body 25 of the upper casing 21; the lower casing 22 is fitted with a cover on the lower end surface of the inhaler, and the One end of the lower casing 22 is open and forms an arc-shaped groove body 25, so that the opening of the inhaler is exposed outside the arc-shaped groove body 25 of the lower casing 22; the plurality of connecting columns 23 are respectively arranged at intervals The inner walls of the upper casing 21 and the lower casing 22 are located at the edges of the upper casing 21 and the lower casing 22, and the plurality of insertion slots 24 are respectively arranged at intervals in the upper casing. On the inner wall of the body 21 and the lower casing 22, at the edge of the upper casing 21 and the lower casing 22, the plurality of connecting columns 23 and the plurality of insertion grooves 24 are matched, so that the described The upper housing 21 is plugged and fixed with the lower housing 22; the detection probe 1 and the controller assembly are respectively arranged in the housing assembly, and a plurality of detection grooves 3 are provided on the inhaler. The detection probe 1 is slidably connected with the detection groove 3 .

Please refer to shown in accompanying drawing 4, described controller assembly comprises main control wireless device 41, position detecting device 42, wireless communication device 43, sound and light reminding device 44 and power supply 45; Described position detecting device 42 and power supply 45 The output terminal is connected to the input terminal of the main control wireless device 41, the wireless communication device 43 is bidirectionally connected to the main control wireless device 41, the wireless communication device 43 is connected to an external smart device, and the The output end of the main control wireless device 41 is connected to the input end of the sound and light reminder device 44 ; the detection probe 1 is connected to the main control wireless device 41 .

The position detecting device 42 is a GPS chip or a GPRS chip whose model is ATK-SIM900, and the position synchronization is realized through the LBS technology of the base station. The cost of this method is relatively high, but the use is more independent.

The wireless communication device 43 is a separate communication device whose model is mcu+ble/gprs/gps.

The wireless communication device 43 is an integrated communication device whose model is NRF51822/CC2541+gprs/gps. Automatically communicate with the smart device through the wireless communication device 43, and obtain the geographical location through the smart device such as a mobile phone. The amount of medicine in a box of inhalers is limited, generally 60 inhalations, and relevant reminder information can be sent to the patient's mobile phone and other smart devices before the medicine is about to be used up.

The sound and light reminding device 44 includes an LED light and a buzzer. In addition to tracking medication information, the present invention also has a medication reminder function. The user can set the time for daily medication. When the medication is not taken beyond the time that should be taken, the acousto-optic reminder device 44 will emit audible and visual reminders.

The power supply 45 adopts a detachable button battery or a rechargeable lithium battery.

The shell assembly is a structure that closely fits the inhaler. The assembly form of the shell assembly is sandwiched. The upper shell 21 and the lower shell 22 clamp the inhaler in the middle, and the connection method is through a multi-point connecting column 23 to fix it. At the same time, the arc-shaped grooves 25 on the edges of the upper shell 21 and the lower shell 22 can prevent the shell components from moving and sliding down.

The detection probe 1 is a part used to detect the working state of the system. The detection probe 1 utilizes the structure of the inhaler itself. When the inhaler is opened, a plurality of detectable detection grooves 3 will appear on the shell of the inhaler. By detecting these By detecting the position of the groove 3, the state of the inhaler can be known.

The detection probe 1 detects the current state of the inhaler by means of opening and closing of the miniature detection switch. When the inhaler is closed, the wall of the inhaler triggers the detection switch, keeping the detection switch in one state. When the user manually turns the inhaler, the detection groove 3 hidden inside will appear.

When the inhaler is opened, the detection probe 1 will move to or pass through the position of the detection groove 3 . At this time, the micro detection switch will be converted to another state, and the controller component can detect its state change at this time.

When the inhaler is turned from open to closed, the controller component will detect the change of the state of the detection probe 1 again, thereby completing a drug detection.

Please refer to the accompanying drawing 5, a tracking method for a drug tracking device, the method at least includes the following steps:

Step 1: System initialization.

Step 2: The detection probe 1 judges whether to perform drug detection, if yes, execute step 3, if not, execute step 4.

Step 3: The main control wireless device 41 records the medication information.

Step 4: The main control wireless device 41 judges whether to remind medication, if yes, execute step 5, if not, execute step 6.

Step 5: Use the acousto-optic reminding device 44 to give audible-optic reminder to take medicine.

Step 6: The master wireless device 41 judges whether to perform data communication, if yes, execute step 7, if not, execute step 8.

Step 7: wirelessly connect the smart device through the wireless communication device 43, and perform data interaction.

Step 8: The controller component enters a low power consumption state, and returns to step 2.

In the step 3, the information of the medication includes information such as the time, dose and location of the medication.

In the description of the present invention, it should be understood that the orientation or positional relationship indicated by the terms "upper", "upper end", "one end", "outside", "lower end", "inner wall" and "inner" are based on the attached The orientation or positional relationship shown in the figure is only for the convenience of describing the present invention and simplifying the description, and does not indicate or imply that the referred device or element must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be construed as a reference to this invention. Invention Limitations.

In the present invention, unless otherwise clearly specified and limited, terms such as "connection" and "fixation" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral body; it can be a mechanical A connection can also be an electrical connection; it can be a direct connection or an indirect connection through an intermediary, and it can be an internal communication between two elements or an interaction relationship between two elements, unless otherwise clearly defined. Those of ordinary skill in the art can understand the specific meanings of the above terms in the present invention according to specific situations.

To sum up, the present invention can automatically record the medication information of the patient, including the time, dose, location, etc. of the medication. These information can be exchanged with the smart device through wireless data, and the medication can be reminded through sound and light.

The above is only a preferred embodiment of the present invention, and does not limit the patent scope of the present invention. Any equivalent structural transformation made by the content of the specification of the present invention, or direct or indirect use of the technical fields attached to other related products, are all the same. The theory is included in the patent protection scope of the present invention.

Claims (8)

1. a kind of medication follow-up mechanism, it is characterised in that：Including casing assembly, detection probe and controller assemblies；Described is outer Shell component is nested on inhalator, and the casing assembly includes upper shell, lower housing, more connecting poles and more insertion grooves； The upper shell is adapted to the cover on the upper surface of inhalator, and the one end open of the upper shell simultaneously forms arc groove body, The opening of inhalator is set to expose outside the arc groove body of the upper shell；The lower housing is adapted to the cover in inhalator On lower face, the one end open of the lower housing simultaneously forms arc groove body, and the opening of inhalator is made to expose in the lower casing Outside the arc groove body of body；The more connecting poles, which are respectively separated, to be arranged on the inner wall of the upper shell and lower housing, Positioned at the edge of the upper shell and lower housing, the more insertion grooves be respectively separated be arranged in the upper shell and On the inner wall of lower housing, it is located at the edge of the upper shell and lower housing, the more connecting poles and more insertion grooves It is adapted, makes the upper shell and the lower housing plugged and fixed；The detection probe and controller assemblies is set respectively It sets in the casing assembly, inhalator is equipped with multiple detection grooves, the detection probe and the detection groove It is slidably connected.

2. medication follow-up mechanism according to claim 1, it is characterised in that：The controller assemblies include that master control is wireless Device, position detecting device, wireless communication device, sound-light reminding device and power supply；The position detecting device and power supply Output end is connect with the input terminal of the master control wireless device, the wireless communication device and the master control wireless device It is bi-directionally connected, the external smart machine of the wireless communication device, the output end of the master control wireless device and the sound The input terminal of light alarm set connects；The detection probe is connect with the master control wireless device.

3. medication follow-up mechanism according to claim 2, it is characterised in that：The position detecting device is GPS chip Or the GPRS chips of model ATK-SIM900, realize that position synchronizes by base station LBS technologies.

4. medication follow-up mechanism according to claim 2, it is characterised in that：The wireless communication device is model The separate type communication device of mcu+ble/gprs/gps.

5. medication follow-up mechanism according to claim 2, it is characterised in that：The wireless communication device is model The integral type communication device of NRF51822/CC2541+gprs/gps.

6. medication follow-up mechanism according to claim 2, it is characterised in that：The power supply is button cell or lithium electricity Pond.

7. a kind of method for tracing using the medication follow-up mechanism described in claim 2, it is characterised in that：This method includes at least Following steps：

Step 1：System initialization；

Step 2：The detection probe judges whether to medication detection, if so, 3 are thened follow the steps, if it is not, thening follow the steps 4；

Step 3：The information of the master control wireless device recording medicine；

Step 4：The master control wireless device judges whether to medication prompting, if so, 5 are thened follow the steps, if it is not, then executing Step 6；

Step 5：Acousto-optic, which is carried out, by the sound-light reminding device reminds medication；

Step 6：The master control wireless device judges whether to data communication, if so, 7 are thened follow the steps, if it is not, then executing Step 8；

Step 7：It is wirelessly connected smart machine by the wireless communication device, and carries out data interaction；

Step 8：The controller assemblies enter low power consumpting state, and return to step 2.

8. the method for tracing of medication follow-up mechanism according to claim 7, it is characterised in that：In the step 3, institute The information for the medication stated includes time, dosage and the place of medication.